AIP
SLXP

Ameritas Investment Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Ameritas Investment Partners’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,579
Closed -$1.66M – 1253
2015
Q1 		$1.66M Buy
9,579
+154
+2% +$22.6K 0.11% 211
2014
Q4 		$1.08M Hold
9,425
– – 0.07% 268
2014
Q3 		$1.47M Sell
9,425
-18
-0.2% -$2.61K 0.11% 215
2014
Q2 		$1.17M Sell
9,443
-222
-2% -$24.5K 0.08% 256
2014
Q1 		$1M Sell
9,665
-243
-2% -$24.9K 0.08% 287
2013
Q4 		$891K Buy
9,908
+133
+1% +$10.6K 0.07% 329
2013
Q3 		$654K Buy
+9,775
New +$674K 0.06% 399

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Ameritas Investment Partners's SLXP Position: Q2 2015 in Review

Ameritas Investment Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 9,579 shares — an estimated $1.66M sold.

Ameritas Investment Partners first reported a position in SLXP in Q3 2013 and held it in 7 quarters. The position peaked at $1.66M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Ameritas Investment Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Ameritas Investment Partners sold 9,579 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.66M.
  • Ameritas Investment Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 7 quarters.
  • Ameritas Investment Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.66M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Ameritas Investment Partners's 13F filing for Q2 2015, filed 7 Aug 2015.